This initiative has been sponsored in part by Mylan Pharmaceuticals through an educational grant.
USING CLOZAPINE: HOW EARLY IS TOO SOON?
The Canadian Consortium for Early Intervention in Psychosis has evaluated the use of clozapine within the first two years of diagnosis of non-affective psychosis. The presentation outlines these results and covers the following educational content:
efficacy and effectiveness of Clozapine for treatment resistant schizophrenia (TRS)
use of Clozapine during the early phase of schizophrenia
expertise in using Clozapine in routine care